glp-1 colorectal cancer death risk study november 2025 Mapping the effectiveness and risks of receptor agonists GLP-1 drugs and colorectal cancer

Surgery : In some cases, surgical treatment may be recommended if a person is not responding to medication

While these medications offer glycemic control and cardiovascular benefits, the risks have increased because of their potential impact on cancer risk, particularly colorectal cancer (CRC)

Compounded medications may be available through licensed compounding pharmacies when medically appropriate and permitted under applicable regulations

Effect of long-acting versus short-acting glucagon-like peptide-1 receptor agonists on improving body weight and related metabolic parameters in type 2 diabetes: A head-to-head meta-analysis

Importantly, they dont act on GLP-1 receptors the way prescription medications do

Tecido adiposo (GIP): pode melhorar a sensibilidade insulina e o metabolismo da gordura